Lisdexamfetamine dimesylate
NDC 72205-137, Lisdexamfetamine dimesylate, tablet, chewable, from Novadoz Pharmaceuticals LLC.
- Product NDC
- 72205-137
- Status
- Listed
- Labeler
- Novadoz Pharmaceuticals LLC
- Dosage form
- TABLET, CHEWABLE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA218306
- DEA schedule
- CII
curl https://api.healthcare.dev/v1/drugs/ndc/72205-137 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LISDEXAMFETAMINE DIMESYLATE60 mg/1
Pharmacologic classes
Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 72205-137-91 | 72205013791 | 100 TABLET, CHEWABLE in 1 BOTTLE (72205-137-91) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/a79cb70c-0bfa-4d68-9a21-a5ef4bc3c811NADAC price for package 72205013791
GET /v1/drugs/nadac/72205013791
Use it
Look up 72205-137 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/72205-137 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 72205-137. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.